Portland, OR, July 04, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global Neuromonitoring Devices Market was estimated at $5.6 billion in 2021 and is expected to hit $10.3 billion by 2030, registering a CAGR of 7.24% from 2022 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and varying market trends.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/16980
Rise in incidence of neurological diseases such as epilepsy, brain tumors, Parkinson’s disease, and Alzheimer’s, especially among the geriatric population, the emergence of neurodegenerative disorders and increase in number of brain injuries drive the growth of the global neuromonitoring devices market. However, high cost of neuromonitoring devices and a scarcity of skilled technicians and personnel impede the market growth. Moreover, the recent expansion of brain tracking in clinical studies is anticipated to create lucrative opportunities in the industry.
Covid-19 scenario-
- The Covid-19 pandemic impacted the neuromonitoring devices market negatively due to reduced patients’ hospital visits and admissions and diminishing demand for neuromonitoring devices.
- Due to the high transmission rate of the disease and severe complications associated with it, healthcare professionals were compelled to postpone many…
